About the case
Bayer (which acquired Monsanto) has paid approximately $11 billion to resolve roughly 100,000 Roundup cancer claims, with additional cases pending. Plaintiffs allege that exposure to glyphosate caused non-Hodgkin's lymphoma and other cancers. Cases continue to be filed; settlement amounts vary based on diagnosis severity and exposure history. This is technically a mass tort rather than a single class action, but the multi-district consolidation makes it operate similarly for plaintiffs.